AU2003202137A1 - Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate - Google Patents

Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Info

Publication number
AU2003202137A1
AU2003202137A1 AU2003202137A AU2003202137A AU2003202137A1 AU 2003202137 A1 AU2003202137 A1 AU 2003202137A1 AU 2003202137 A AU2003202137 A AU 2003202137A AU 2003202137 A AU2003202137 A AU 2003202137A AU 2003202137 A1 AU2003202137 A1 AU 2003202137A1
Authority
AU
Australia
Prior art keywords
anhydrate
hydrate
preparing
processes
erythromycin derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003202137A
Other languages
English (en)
Inventor
Vandana K. Cheruvallath
Akira Hiraide
Kenji Kamada
Kaichiro Koyama
Stephan Parent
Hitoshi Shimizu
Gary H. Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of AU2003202137A1 publication Critical patent/AU2003202137A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU2003202137A 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate Abandoned AU2003202137A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2002004680 2002-01-11
JP2002-004680 2002-01-11
JP2002076708 2002-03-19
JP2002-076708 2002-03-19
PCT/JP2003/000203 WO2003068793A1 (en) 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Publications (1)

Publication Number Publication Date
AU2003202137A1 true AU2003202137A1 (en) 2003-09-04

Family

ID=27736409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003202137A Abandoned AU2003202137A1 (en) 2002-01-11 2003-01-14 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate

Country Status (7)

Country Link
US (1) US20050176938A1 (enExample)
EP (1) EP1463743A1 (enExample)
JP (1) JP2005519934A (enExample)
AU (1) AU2003202137A1 (enExample)
CA (1) CA2472603A1 (enExample)
TW (1) TW200302830A (enExample)
WO (1) WO2003068793A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10339882A1 (de) * 2003-06-26 2005-01-13 Continental Teves Ag & Co. Ohg Hydraulikaggregat für schlupfgeregelte Bremsanlagen
US7141769B2 (en) * 2005-04-01 2006-11-28 Cem Corporation Spectroscopy-based real-time control for microwave-assisted chemistry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY113693A (en) * 1992-05-26 2002-05-31 Chugai Pharmaceutical Co Ltd Erythromycin derivatives having an enterokinesis stimulating action
JP3258914B2 (ja) * 1995-08-03 2002-02-18 中外製薬株式会社 エリスロマイシン誘導体の製造方法
ZA966601B (en) * 1995-08-03 1997-02-19 Chugai Pharmaceutical Co Ltd Process for producing erythromycin derivatives.
US5945405A (en) * 1997-01-17 1999-08-31 Abbott Laboratories Crystal form O of clarithromycin
SK142000A3 (en) * 1997-07-08 2000-06-12 Biochemie Sa Erythromycin a oxime solvates

Also Published As

Publication number Publication date
TW200302830A (en) 2003-08-16
US20050176938A1 (en) 2005-08-11
JP2005519934A (ja) 2005-07-07
EP1463743A1 (en) 2004-10-06
CA2472603A1 (en) 2003-08-21
WO2003068793A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2003232330A1 (en) Method of preparing microparticles
AU2003290758A1 (en) System and method for discovery and configuration
AU2002237527A1 (en) Method of synthesizing camptothecin-relating compounds
AU2003286588A1 (en) Methods for synthesizing complementary dna
AU2003270310A1 (en) Compositions and methods for synthesizing nucleic acids
AU2003205999A1 (en) Method of and system for multi-path communication
AU2003277596A1 (en) Method of deuterization
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2003293122A1 (en) Methods for synthesizing polysaccharides
AU2003258927A1 (en) Method and system of positioning
AU2003267888A1 (en) Method and system of positioning
AU2003214609A1 (en) Derivatives of isoflavones
AU2003218704A1 (en) Process for preparing 2-aminoindan derivatives
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives
AU2003202137A1 (en) Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
AU2003256102A1 (en) Method for the selective preparation of 3-oxo-4-aza-5a-androstane compound
AU2003241100A1 (en) Process for preparing high purity azithromycin
AU2003225049A1 (en) Polymorph of ascomycin derivative
AU2003300874A1 (en) Crystalline forms of gatifloxacin and processes for preparation
AU2003235231A1 (en) Method of synthesizing cf3-chf-cf2-nr2
ZA200507475B (en) Derivatives of azithromycin
AU2002255305A1 (en) Lactam synthesizing method
IL164407A0 (en) Processes for preparing heteroaryl and unsaturatedheterocycloalkylmagnesium compounds
AU2003263155A1 (en) Method for manufacture of dihydroisobenzofuran derivatives
AU2002242939A1 (en) Process for isolation of eupalitin (3-0-beta-d-galactopyranoside) from boerhavia diffusa

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase